醫思健康(02138.HK)擬收購獸醫業務
格隆匯8月16日丨醫思健康(02138.HK)發佈公吿,2021年8月16日,公司及其全資附屬公司(作為買方)與兩名在香港註冊的獸醫訂立協議,據此,賣方有條件同意出售兩家在香港經營獸醫醫院的目標公司的全部已發行股本。
根據協議的條款及條件,收購事項將分兩期完成,包括(i)該等目標公司已發行股本的51%,代價為2620萬港元;(ii)該等目標公司餘下49%的已發行股本,代價基於將以根據該等目標公司將達到的税後淨利潤水平的市盈率;及該等目標公司目前的財務表現。在任何情況下,最後一期收購的代價將不超過4067萬港元。
根據披露,該等目標公司主要在香港提供獸醫服務。截至該公吿日期,該等目標公司於香港經營5間獸醫醫院,擁有16名註冊獸醫。鑑於香港對獸醫服務的需求,加上香港獸醫市場比較分散,以及醫療診所與動物診所的業務相似,公司旨在整合獸醫市場,並促進香港獸醫業務企業化。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.